FDM Group (Holdings) plc (FDM):企業の財務・戦略的SWOT分析

◆英語タイトル:FDM Group (Holdings) plc (FDM) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0366
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Business and Consumer Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

FDM Group (Holdings) plc (FDM) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

FDM Group (Holdings) plc (FDM) is an international professional information technology (IT) service provider. The company recruits, trains, and places IT and business consultants across various technical and business disciplines, which include development, testing, project management office, data and operational analysis, business analysis, business intelligence, production support and client training. FDM offers services to various sectors, such as finance, insurance, logistics, media, retail, systems integration, logistics, telecommunications and transport. The company has training academies and sales operations in London, Manchester, Glasgow, New York, Toronto and Frankfurt and sales office in Hong Kong. FDM is headquartered in London, the UK.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
FDM Group (Holdings) plc – Key Facts
FDM Group (Holdings) plc – Key Employees
FDM Group (Holdings) plc – Key Employee Biographies
FDM Group (Holdings) plc – Major Products and Services
FDM Group (Holdings) plc – History
FDM Group (Holdings) plc – Company Statement
FDM Group (Holdings) plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
FDM Group (Holdings) plc – Business Description
Geographical Segment: APAC
Performance
Key Stats
Geographical Segment: EMEA
Performance
Key Stats
Geographical Segment: North America
Performance
Key Stats
Geographical Segment: UK and Ireland
Performance
Key Stats
FDM Group (Holdings) plc – Corporate Strategy
FDM Group (Holdings) plc – SWOT Analysis
SWOT Analysis – Overview
FDM Group (Holdings) plc – Strengths
FDM Group (Holdings) plc – Weaknesses
FDM Group (Holdings) plc – Opportunities
FDM Group (Holdings) plc – Threats
FDM Group (Holdings) plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
FDM Group (Holdings) plc, Key Facts
FDM Group (Holdings) plc, Key Employees
FDM Group (Holdings) plc, Key Employee Biographies
FDM Group (Holdings) plc, Major Products and Services
FDM Group (Holdings) plc, History
FDM Group (Holdings) plc, Other Locations
FDM Group (Holdings) plc, Subsidiaries
FDM Group (Holdings) plc, Key Competitors
FDM Group (Holdings) plc, Ratios based on current share price
FDM Group (Holdings) plc, Annual Ratios
FDM Group (Holdings) plc, Annual Ratios (Cont...1)
FDM Group (Holdings) plc, Annual Ratios (Cont...2)
FDM Group (Holdings) plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
FDM Group (Holdings) plc, Performance Chart (2014 - 2018)
FDM Group (Holdings) plc, Ratio Charts

★海外企業調査レポート[FDM Group (Holdings) plc (FDM):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • London North West Healthcare NHS Trust:企業の戦略的SWOT分析
    London North West Healthcare NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Innate Pharma SA (IPH)-製薬・医療分野:企業M&A・提携分析
    Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclo …
  • Alphanosos SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Alphanosos SAS (Alphanosos) is a developer of novel therapies for the treatment of chronic inflammatory diseases. The company offers pure antibiofilms and antibiotics. It concentrates on bacterial biofilms in various therapeutic areas such as dermatological, bucco-dental and respiratory dise …
  • Knoll, Inc.:戦略・SWOT・企業財務分析
    Knoll, Inc. - Strategy, SWOT and Corporate Finance Report Summary Knoll, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Natural Resource Partners L.P.:企業のM&A・事業提携・投資動向
    Natural Resource Partners L.P. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Natural Resource Partners L.P. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Edge Therapeutics Inc (EDGE):企業の財務・戦略的SWOT分析
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • Integrated Silicon Solution, Inc.:企業の戦略的SWOT分析
    Integrated Silicon Solution, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務情報
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Evotec AG (EVT):製薬・医療:M&Aディール及び事業提携情報
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • AAR Corp:企業の戦略・SWOT・財務情報
    AAR Corp - Strategy, SWOT and Corporate Finance Report Summary AAR Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Neurim Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Neurim Pharmaceuticals Ltd (Neurim) is a drug discovery company that develops drugs for central nervous system diseases.The company's product line includes circadin that is used in insomnia treatment. Neurim offers paediatric prolonged-release melatonin, piromelatine, NEU-P12 and NEU-240. Th …
  • PHINMA Energy Corp (TAPET):企業の財務・戦略的SWOT分析
    Summary PHINMA Energy Corp (PHINMA), formerly Trans-Asia Oil and Energy Development Corp, is an oil and gas company that explores and develops oil and gas interest and geothermal energy. The company operates through business division such as power, wind energy, and energy resource development. Its p …
  • NanoSmart Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary NanoSmart Pharmaceuticals Inc (NanoSmart) focuses on the development of novel methods for the treatment of cancer and other diseases. The company is evaluating a human-derived anti-nuclear antibody which targets areas of necrosis presence in various different types of cancer tumors. Its prop …
  • Monteloeder S.L.:企業の戦略・SWOT・財務情報
    Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report Summary Monteloeder S.L. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary AvidBiotics Corp (AvidBiotics) is a pharmaceutical company that develops non-antibody therapeutic proteins targeting cancer cells, virus-infected cells and pathogenic bacteria. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include …
  • Unfors RaySafe AB:医療機器:M&Aディール及び事業提携情報
    Summary Unfors RaySafe AB (Unfors), formerly Unfors Instruments AB, is a subsidiary of Fluke Biomedical, medical device company that provides solution for the X-ray room consisting of products which collect radiation. The company’s products include RaySafe ThinX, RaySafe X2, RaySafe Solo, RaySafe Xi …
  • Prinova Group LLC:企業の戦略・SWOT・財務情報
    Prinova Group LLC - Strategy, SWOT and Corporate Finance Report Summary Prinova Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Clean Energy Fuels Corp (CLNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Energy Fuels Corp (Clean Energy) is an oil and gas company that offers natural gas fuel transportation services. The company’s products fuels, liquefied natural gas, compressed natural gas, renewable natural gas, and bulk fuels. It also provides storage systems, compressors, dispensers …
  • Kuros Biosciences Ltd (KURN)-製薬・医療分野:企業M&A・提携分析
    Summary Kuros Biosciences Ltd (Kuros Biosciences) is a biotechnology company that develops products for tissue repair and regeneration. It develops a family of bone healing products to address indications in trauma and spine called orthobiologics. It is focused on bone repair for trauma, specificall …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆